|
|
||||||||
Original Research |
1 Russell H. Morgan Department of Radiology and Radiological Science, Johns
Hopkins University School of Medicine and Johns Hopkins Medical Institutions,
601 N Caroline St., JHOC 3171C, Baltimore, MD 21287.
2 Department of Radiology, Johns Hopkins University School of Medicine,
Baltimore, MD.
3 Division of MR Research, Department of Radiology, Johns Hopkins University
School of Medicine, Baltimore, MD.
4 Department of Radiology, Health Science Informatics, Johns Hopkins University
School of Medicine, Baltimore, MD.
5 Division of Orthopaedics and Oncology, Department of Orthopaedic Surgery,
Johns Hopkins Medical Institutions, Baltimore, MD.
6 Department of Pathology, Johns Hopkins Medical Institutions, Baltimore,
MD.
7 MRI Division, Russell H. Morgan Department of Radiology and Radiological
Science, Johns Hopkins Medical Institutions, Baltimore, MD.
OBJECTIVE. The purpose of our study was to determine the feasibility and value of proton MR spectroscopy at 3 T for characterizing musculoskeletal tumors.
SUBJECTS AND METHODS. At 3 T, 18 patients with musculoskeletal lesions (four histologically proven to be malignant, 14 proven benign histologically or at clinical follow-up) underwent 23 MR spectroscopy studies, 20 with a single-voxel technique and three with a multivoxel technique. Seventeen patients were imaged with a surface coil and six with a body coil. Choline signal (3.2 ppm) was measured in each voxel and expressed relative to background noise as signal-to-noise ratio (SNR). Choline SNRs of malignant tumors and benign lesions were compared.
RESULTS. Diagnostic spectra were obtained in 20 of 23 lesions. For malignant lesions (osteosarcoma with two MR spectroscopy sites, metastasis, grade 1 sarcoma), choline SNRs were 5.2 and 4.2 (performed with body coil) and 4.8 and 18.7 (performed with surface coil), respectively. For benign lesions (neurofibroma, two stress reactions, bone cyst, hemangioma, lipoma, Baker cyst), choline SNR was 6.3 (with surface coil), 5.5 (with surface coil), and not detected for five cases. Seven postoperative patients with myocutaneous flaps showed either the typical spectrum of muscle or negligible choline. Only a water peak existed in a bone cyst and a significant lipid peak in a lipoma. Choline SNRs were different for malignant and benign lesions (11.7 vs 2.3, p = 0.04, as performed with a surface coil).
CONCLUSION. At 3 T, both single-voxel and multivoxel MR spectroscopy are feasible. Proton MR spectroscopy is a potential noninvasive tool for characterizing lesion composition and malignant activity.
Keywords: bone MRI MR spectroscopy MR technique oncologic imaging soft-tissue neoplasms
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. L. Sah, R. Sharma, H. Kandpal, A. Seith, S. Rastogi, S. Bandhu, and N. R. Jagannathan In Vivo Proton Spectroscopy of Giant Cell Tumor of the Bone Am. J. Roentgenol., February 1, 2008; 190(2): W133 - W139. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |